Applied Tissue Technologies LLC was founded in 2000 with the aim to bring advanced wound healing technologies to patients. Focused on medical innovation driven by science, Applied Tissue is headquartered in the Boston suburb of Hingham, MA. A Global portfolio of Patented treatment methods and proprietary devices enable care givers to heal wounds more efficiently in established economic zones and additionally in undeveloped and developing countries through the use of non-powered and battery powered technologies.

The company is focusing its research initiatives in advanced wound healing technologies in the area of Prolonged Field Care and Regenerative Medicine with the continued support of the US Department of Defense, the US Army, the Defense Health Agency and the SBIR.  Applied Tissue’s initiatives include the development and commercialization of a multi-modal negative pressure wound therapy platform technology that eliminates foam or gauze wound contact layer required in currently available competing devices. 

We believe that this technology called the Platform Wound Device “PWD” will have a major impact in treating traumatic injuries and burns in the war fighter and may provide answers to some of the challenges presented with the currently available NPWT technology. The PWD’s properties will also enable, fast, wide-spread deployment during a large scale civilian casualty event, as well as support the daily treatment of common acute and chronic wounds.  The technology will support immediate delivery of topical therapeutics to include analgesia, antimicrobial and other liquid, gel or ointment formulations.